Dr. Anz III Bertrand

Claim this profile

Tennessee Oncology, PLLC

Studies Follicular Lymphoma
Studies Lymphoma
1 reported clinical trial
3 drugs studied

Area of expertise

1Follicular Lymphoma
Anz III Bertrand has run 1 trial for Follicular Lymphoma. Some of their research focus areas include:
EZH2 positive
CNG positive
CNG negative
2Lymphoma
Anz III Bertrand has run 1 trial for Lymphoma. Some of their research focus areas include:
EZH2 positive
CNG positive
CNG negative

Affiliated Hospitals

Image of trial facility.
Tennessee Oncology, PLLC

Clinical Trials Anz III Bertrand is currently running

Image of trial facility.

Tazemetostat + Lenalidomide + Rituximab

for Follicular Lymphoma

The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria

More about Anz III Bertrand

Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Anz III Bertrand has experience with
  • Lenalidomide
  • Rituximab
  • Tazemetostat
Breakdown of trials Anz III Bertrand has run
Follicular Lymphoma
Lymphoma

Other Doctors you might be interested in

Denise YardleySarah Cannon Research Institute
Melissa Johnson, MDTennessee Oncology - Nashville
Erika P HamiltonTennessee Oncology-Nashville/Sarah Cannon Research Institute

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anz III Bertrand specialize in?
Anz III Bertrand focuses on Follicular Lymphoma and Lymphoma. In particular, much of their work with Follicular Lymphoma has involved EZH2 positive patients, or patients who are CNG positive.
Is Anz III Bertrand currently recruiting for clinical trials?
Yes, Anz III Bertrand is currently recruiting for 1 clinical trial in Chattanooga Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Anz III Bertrand has studied deeply?
Yes, Anz III Bertrand has studied treatments such as Lenalidomide, Rituximab, Tazemetostat.
What is the best way to schedule an appointment with Anz III Bertrand?
Apply for one of the trials that Anz III Bertrand is conducting.
What is the office address of Anz III Bertrand?
The office of Anz III Bertrand is located at: Tennessee Oncology, PLLC, Chattanooga, Tennessee 37404 United States. This is the address for their practice at the Tennessee Oncology, PLLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top